Frontiers in Microbiology (Jan 2020)

Comparing Cathelicidin Susceptibility of the Meningitis Pathogens Streptococcus suis and Escherichia coli in Culture Medium in Contrast to Porcine or Human Cerebrospinal Fluid

  • Marita Meurer,
  • Marita Meurer,
  • Nicole de Buhr,
  • Nicole de Buhr,
  • Linn Meret Unger,
  • Linn Meret Unger,
  • Marta C. Bonilla,
  • Marta C. Bonilla,
  • Jana Seele,
  • Jana Seele,
  • Roland Nau,
  • Roland Nau,
  • Christoph G. Baums,
  • Thomas Gutsmann,
  • Stefan Schwarz,
  • Maren von Köckritz-Blickwede,
  • Maren von Köckritz-Blickwede

DOI
https://doi.org/10.3389/fmicb.2019.02911
Journal volume & issue
Vol. 10

Abstract

Read online

Host defense peptides or antimicrobial peptides (AMPs), e.g., cathelicidins, have recently been discussed as a potential new treatment option against bacterial infections. To test the efficacy of AMPs, standardized methods that closely mimic the physiological conditions at the site of infection are still needed. The aim of our study was to test the meningitis-causing bacteria Streptococcus suis and Escherichia coli for their susceptibility to cathelicidins in culture medium versus cerebrospinal fluid (CSF). Susceptibility testing was performed in analogy to the broth microdilution method described by the Clinical and Laboratory Standard Institute (CLSI) to determine minimum inhibitory concentrations (MICs) of antimicrobial agents. MICs were determined using cation-adjusted Mueller–Hinton broth (CA-MHB), lysogeny broth (LB), Roswell Park Memorial Institute medium (RPMI) or Dulbecco’s Modified Eagle’s Medium (DMEM) (the latter two supplemented with 5% CA-MHB or blood) and compared with MICs obtained in porcine or human CSF. Our data showed that MICs obtained in CA-MHB as recommended by CLSI do not reflect the MICs obtained in the physiological body fluid CSF. However, the MICs of clinical isolates of S. suis tested in RPMI medium supplemented with CA-MHB, were similar to those of the same strains tested in CSF. In contrast, the MICs in the human CSF for the tested E. coli K1 strain were higher compared to the RPMI medium and showed even higher values than in CA-MHB. This highlights the need for susceptibility testing of AMPs in a medium that closely mimics the clinically relevant conditions.

Keywords